A pilot study of irinotecan (CPT-11) as single-agent therapy in patients with locally advanced or metastatic esophageal carcinoma

被引：0
|
作者：
F. Mühr-Wilkenshoff
W. Hinkelbein
I. Ohnesorge
K. J. Wolf
E.-O. Riecken
M. Zeitz
H. Scherübl
机构：
[1] University Hospital Benjamin Franklin,Medical Clinic I
[2] University Hospital Benjamin Franklin,Department of Radiotherapy
[3] University Hospital Benjamin Franklin,Department of Radiology
来源：
International Journal of Colorectal Disease | 2003年 / 18卷
关键词：
Esophageal carcinoma; Irinotecan; CPT-11; Chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：330 / 334
页数：4
相关论文
共 50 条
  • [1] A pilot study of irinotecan (CPT-11) as single-agent therapy in patients with locally advanced or metastatic esophageal carcinoma
    Mühr-Wilkenshoff, F
    Hinkelbein, W
    Ohnesorge, I
    Wolf, KJ
    Riecken, EO
    Zeitz, M
    Scherübl, H
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2003, 18 (04) : 330 - 334
  • [2] Efficacy of CPT-11 (irinotecan) as a single agent in metastatic colorectal cancer
    Shimada, Y
    Rougier, P
    Pitot, H
    EUROPEAN JOURNAL OF CANCER, 1996, 32A : S13 - S17
  • [3] First results of a novel study of irinotecan (CPT-11) in patients with advanced esophageal squamous cell carcinoma and adenocarcinoma
    Muehr-Wilkenshoff, FB
    Grabowski, P
    Hinkelbein, WG
    Ohnesorge, I
    Wolf, KJ
    Schulzke, JD
    Scheruebl, H
    GASTROENTEROLOGY, 2001, 120 (05) : A443 - A443
  • [4] Phase II study of irinotecan (CPT-11) as salvage therapy for advanced nasopharyngeal carcinoma
    Poon, D
    Chowbay, B
    Cheung, YB
    Leong, SS
    Tan, EH
    CANCER, 2005, 103 (03) : 576 - 581
  • [5] Response of hepatoblastoma heavily treated and relapsed in the transplanted liverto single-agent therapy with irinotecan hydrochloride (CPT-11).
    Ijichi, O
    Isikawa, S
    Shinkoda, Y
    Tanabe, T
    Takamatsu, H
    Inomata, Y
    Kawano, Y
    PEDIATRIC TRANSPLANTATION, 2005, 9 : 68 - 68
  • [6] EFFICACY OF COMBINATION CHEMOTHERAPY WITH IRINOTECAN (CPT-11) PLUS CAPECITABINE IN PATIENTS WITH METASTATIC OR ADVANCED COLORECTAL CARCINOMA
    Gennatas, C.
    Michalaki, V.
    Gennatas, S.
    Voros, D.
    ANNALS OF ONCOLOGY, 2008, 19 : 148 - 148
  • [7] Phase II study of irinotecan (CPT-11) as salvage therapy for advanced nasopharyngeal carcinoma (NPC).
    Poon, D
    Chowbay, B
    Leong, SS
    Cheung, YB
    Toh, CK
    Tay, MH
    Lim, WT
    Tan, EH
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 507S - 507S
  • [8] A phase II study of irinotecan (CPT-11) in patients with advanced squamous cell carcinoma of the cervix
    Irvin, WP
    Price, FV
    Bailey, H
    Gelder, M
    Rosenbluth, R
    Durivage, HJ
    Potkul, RK
    CANCER, 1998, 82 (02) : 328 - 333
  • [9] Neoadjuvant radiochemotherapy with irinotecan (CPT-11) and capecitabine in locally advanced rectal cancer
    Kraus-Tiefenbacher, U
    Hofheinz, R
    von Gerstenberg-Heffdorf, B
    Willeke, F
    Hochhaus, A
    Wenz, F
    STRAHLENTHERAPIE UND ONKOLOGIE, 2004, 180 : 31 - 31
  • [10] Capecitabine (X) single-agent therapy in patients (pts) with locally advanced/metastatic cholangiocarcinoma
    Sew, O. Sea
    Sookprasert, A.
    Bhudhisawad, V.
    Kaewket, V.
    Pirojkul, C.
    ANNALS OF ONCOLOGY, 2004, 15 : 53 - 54
12345